Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $13,201 | 888 | 98.0% |
| Education | $273.50 | 5 | 2.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,483 | 124 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,376 | 83 | $0 (2024) |
| Amgen Inc. | $1,316 | 74 | $0 (2024) |
| GlaxoSmithKline, LLC. | $988.83 | 87 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $855.52 | 53 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $843.31 | 46 | $0 (2024) |
| Lilly USA, LLC | $795.03 | 62 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $740.38 | 39 | $0 (2023) |
| Astellas Pharma US Inc | $662.04 | 28 | $0 (2024) |
| Merck Sharp & Dohme LLC | $615.92 | 66 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,541 | 95 | AstraZeneca Pharmaceuticals LP ($257.65) |
| 2023 | $1,632 | 100 | AstraZeneca Pharmaceuticals LP ($176.40) |
| 2022 | $1,950 | 122 | Amgen Inc. ($192.06) |
| 2021 | $1,884 | 127 | Janssen Pharmaceuticals, Inc ($309.95) |
| 2020 | $1,632 | 108 | Novo Nordisk Inc ($220.67) |
| 2019 | $1,960 | 126 | Janssen Pharmaceuticals, Inc ($397.37) |
| 2018 | $1,693 | 114 | Janssen Pharmaceuticals, Inc ($357.39) |
| 2017 | $1,183 | 101 | Novo Nordisk Inc ($247.77) |
All Payment Transactions
893 individual payment records from CMS Open Payments — Page 1 of 36
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: DERMATOLOGY | ||||||
| 12/10/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Respiratory | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: RESPIRATORY | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: RESPIRATORY | ||||||
| 11/21/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $22.71 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 11/21/2024 | PFIZER INC. | VYNDAMAX (Drug) | Food and Beverage | In-kind items and services | $18.86 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/19/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.58 | General |
| Category: Cardiovascular | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: RESPIRATORY | ||||||
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Respiratory | ||||||
| 11/08/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: Hematology | ||||||
| 11/07/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: UROLOGY | ||||||
| 11/07/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Oncology | ||||||
| 11/05/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $18.06 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/01/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: VACCINES | ||||||
| 10/31/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $13.94 | General |
| Category: Biological | ||||||
| 10/29/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Inflammation | ||||||
| 10/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: Diabetes | ||||||
| 10/24/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.81 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: RESPIRATORY | ||||||
| 10/04/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: Respiratory | ||||||
| 09/27/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: Inflammation | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Respiratory | ||||||
| 09/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.67 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 16 | 1,909 | 2,438 | $286,540 | $81,720 |
| 2022 | 20 | 1,890 | 2,409 | $279,140 | $82,388 |
| 2021 | 20 | 2,149 | 2,632 | $250,296 | $158,155 |
| 2020 | 18 | 1,929 | 2,389 | $232,025 | $132,770 |
All Medicare Procedures & Services
74 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 252 | 507 | $74,448 | $21,437 | 28.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 287 | 392 | $77,161 | $18,540 | 24.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 311 | 311 | $68,992 | $15,490 | 22.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 122 | 185 | $22,393 | $7,177 | 32.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 33 | 39 | $11,577 | $4,104 | 35.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 210 | 210 | $5,250 | $3,862 | 73.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 16 | 16 | $3,709 | $2,292 | 61.8% |
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 13 | 15 | $2,240 | $2,097 | 93.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 21 | 21 | $4,659 | $1,613 | 34.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 116 | 164 | $5,740 | $1,561 | 27.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 320 | 355 | $3,550 | $1,211 | 34.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 83 | 87 | $3,480 | $762.45 | 21.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 66 | 75 | $1,125 | $630.00 | 56.0% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 29 | 29 | $730.00 | $533.31 | 73.1% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 18 | 18 | $450.00 | $280.80 | 62.4% |
| 69209 | Removal of impacted ear wax by washing | Office | 2023 | 12 | 14 | $1,036 | $129.15 | 12.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 279 | 502 | $70,618 | $22,351 | 31.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 302 | 429 | $81,850 | $20,142 | 24.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 293 | 293 | $60,574 | $15,041 | 24.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 103 | 176 | $20,230 | $7,013 | 34.7% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 27 | 27 | $5,967 | $3,817 | 64.0% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 131 | 131 | $3,350 | $2,429 | 72.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 22 | 26 | $7,592 | $1,811 | 23.8% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 109 | 149 | $5,215 | $1,428 | 27.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 20 | 20 | $4,144 | $1,341 | 32.4% |
About Dr. Larry Baylis, D.O
Dr. Larry Baylis, D.O is a Family Medicine healthcare provider based in Clarkston, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/08/2006. The National Provider Identifier (NPI) number assigned to this provider is 1902847510.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Larry Baylis, D.O has received a total of $13,475 in payments from pharmaceutical and medical device companies, with $1,541 received in 2024. These payments were reported across 893 transactions from 52 companies. The most common payment nature is "Food and Beverage" ($13,201).
As a Medicare-enrolled provider, Baylis has provided services to 7,877 Medicare beneficiaries, totaling 9,868 services with total Medicare billing of $455,034. Data is available for 4 years (2020–2023), covering 74 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Clarkston, MI
- Active Since 06/08/2006
- Last Updated 09/06/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1902847510
Products in Payments
- XARELTO (Drug) $1,046
- TRELEGY ELLIPTA (Drug) $565.61
- Ozempic (Drug) $541.22
- EVENITY (Biological) $486.60
- JANUVIA (Drug) $459.74
- Vascepa (Drug) $418.37
- ELIQUIS (Drug) $367.43
- SOLIQUA 100/33 (Biological) $361.29
- TRULICITY (Drug) $356.08
- FARXIGA (Drug) $350.36
- BREZTRI (Drug) $349.30
- INVOKANA (Drug) $330.51
- STIOLTO RESPIMAT (Drug) $310.21
- ENTRESTO (Drug) $302.07
- VRAYLAR (Drug) $289.72
- Otezla (Drug) $285.64
- Aimovig (Biological) $275.53
- Victoza (Drug) $215.88
- Saxenda (Drug) $184.22
- TRADJENTA (Drug) $183.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Clarkston
Dorothy White-Williams, M.d, M.D
Family Medicine — Payments: $7,926
Dr. Joyce Lewis, M.d, M.D
Family Medicine — Payments: $7,511
Dr. Katherine French, Do, DO
Family Medicine — Payments: $7,438
Dr. Timothy Oneill, Do, DO
Family Medicine — Payments: $6,524
Dr. Salomi Rami, Do, DO
Family Medicine — Payments: $6,150
Grant Below, Do, DO
Family Medicine — Payments: $6,113